[Monitoring of the treatment of endogenous depression with imipramine and amitriptyline (preliminary report)].
Monitored treatment of a depressed phase of unipolar affective disorder was conducted in 11 female patients receiving imipramine and in 12 females taking amitriptyline. Patients were randomly assigned to one of the drug and in 6 patients the drugs were switched because of the lack of response to the first used compound. In the imipramine treated group a satisfactory response after 4 weeks of management (less than 6 points on Hamilton's depression scale) was observed in 6 patients and in amitriptyline treated group in 5 patients. Patients displaying a satisfactory response to amitryptyline had significantly higher--as compared to remaining patients in the group--plasma levels of the drug after two and four weeks of treatment. Such an association was not observed in patients treated wtih imipramine. Severity of depression and motor retardation before the treatment was similar both in patients with satisfactory and with poor response to imipramine as well as to amitriptyline. However the intensity of anxiety symptoms was higher in patients exhibiting poor response to treatment with amitriptyline and imipramine as well.
Rybakowski
J
J
Katedry i Kliniki Psychiatrii AM, Bydgoszczy.
Matkowski
K
K
Linka
M
M
Kasprowicz-Dabrowiecka
A
A
Kanarkowski
R
R
Lehmann
W
W
Krzyzanowski
M
M
D000328:Adult; D000368:Aged; D000639:Amitriptyline / Q000097:blood / Q000627:therapeutic use*; D003866:Depressive Disorder / Q000097:blood / Q000188:drug therapy*; D016903:Drug Monitoring; D004351:Drug Resistance; D005260:Female; D006801:Humans; D007099:Imipramine / Q000097:blood / Q000627:therapeutic use*; D008875:Middle Aged; D012074:Remission Induction; D013997:Time Factors
D000639:Amitriptyline; D007099:Imipramine
Monitorowane leczenie depresji endogennej imipramina i amitryptylina (doniesienie wstepne).